Osgood–Schlatter disease (OSD), also known as apophysitis of the tibial tubercle, is inflammation of the patellar ligament at the tibial tuberosity. It is characterized by a painful bump just below the knee that is worse with activity and better with rest. Episodes of pain typically last a few months. One or both knees may be affected and flares may recur.
About 4% of people are affected at some point in time by Osgood-Schlatter. Males between the ages of 10 and 15 are most often affected. After growth slows, typically age 16 in boys and 14 in girls, the pain will no longer occur despite a bump potentially remaining.

Market Analysis and Insights: Global Osgood-Schlatter Market
The global Osgood-Schlatter market size is projected to reach US$ 3411.4 million by 2027, from US$ 2818 million in 2020, at a CAGR of 2.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osgood-Schlatter market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osgood-Schlatter market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osgood-Schlatter market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osgood-Schlatter market.

Global Osgood-Schlatter Scope and Market Size
Osgood-Schlatter market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osgood-Schlatter market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Physical Therapy
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Djo Global
Teva Pharmaceutical Industries
Breg
Bayer Healthcare Pharmaceuticals
Pfizer
Daiichi Sankyo Company